Muhamad NDA, Kanie N, Otsubo Y, Suzuki K, et al. Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC class II deficiency. J Infect Chemother 2025;31:102627.
PMID: 39863069